Ultra N-Geneous Hdl Cholesterol Reagent 1/Reagent2 and 1 more
Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl. 510(k) K021316, from Genzyme Corp. (Cambridge, MA). Product code LBS, class 1.
As of Nov 19, 2026, K021316 is an FDA 510(k) held by Genzyme Corp., substantially equivalent on Jul 25, 2002 after 91 days, with no recalls tied to it in FDA's recall database.
- Review time: 91 days
- Recalls: 0
- Cited as a predicate by: 7 devices
Reagent: For the quantitative determination of high-density cholesterol lipoprotein cholesterol in human serum or plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus, atherosclerosis and various liver and renal diseases). For In Vitro Diagnostic Use Calibrator: For calibration of the Ultra HDL Cholesterol assay.
- Atellica® CH HDL Cholesterol (HDLC)& Atellica® CH LDL Cholesterol (LDLC)K241800 · Siemens Healthcare Diagnostics, Inc. · Jul 26, 2024
- HDL-Cholesterol Gen.4K162593 · Roche Diagnostics Operations (Rdo) · Oct 19, 2016
- Elitech Clincal Systems Cholesterol Hdl SL 2G, Hdl 2G Calibrator, Ldl SL 2G, Ldl 2G Calibrator, Elitrol Ii & Elitech SysK103747 · Elitechgroup Seppim S.A.S. · Aug 31, 2011
- Diazyme Hdl-Cholesterol Reagent,Calibrator, ControlsK072395 · Diazyme Laboratories · Jan 3, 2008
- Abx Pentra 400: LipoproteinsK060854 · Horiba Abx · Aug 24, 2006
- Ultra HdlK051962 · Abbott Laboratories · Aug 25, 2005
- Hdl-Ex Seiken Assay KitK041090 · Denka Seiken Co., Ltd. · Oct 29, 2004
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 25, 2002
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files